Braveheart Bio, Inc.
BRVE
IPO
$28.91
-$0.50-1.70%
NASDAQ
IPO Factors
Debt Ratio
Growth Ratio
Industry
Institutional Support
Investment
IPO Size
Management
Market Reaction
Profitability
Revenue
Revenue Growth
Syndicate Size
Valuation
Headlines
8/31/2026
-
MarketBeat
9/9/2026
-
TipRanks
9/8/2026
-
MarketBeat
9/8/2026
-
The Cerbat Gem
9/8/2026
-
Globe Newswire
9/8/2026
-
MarketBeat
9/8/2026
-
MarketBeat
9/1/2026
-
Globe Newswire
9/1/2026
-
MarketBeat
9/1/2026
-
MarketBeat
8/31/2026
-
MarketBeat
8/31/2026
-
The Cerbat Gem
8/31/2026
-
MarketBeat
8/31/2026
-
MarketBeat
8/31/2026
-
MarketBeat
8/31/2026
-
TipRanks: TheFly
8/31/2026
-
TipRanks: TheFly
8/31/2026
-
TipRanks: TheFly
8/31/2026
-
TipRanks: TheFly
8/31/2026
-
TipRanks: TheFly
8/31/2026
-
TipRanks: TheFly
8/7/2026
-
Globe Newswire
8/6/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, July 15, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Jul 12 and 16 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
415 707 6312
Address
One Letterman Drive
Building A
Suite A4-300
San Francisco, CA 94129
Building A
Suite A4-300
San Francisco, CA 94129
Country
Year Founded
Business Description
Sector
Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. It...
more